12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Friday's intraday session, several healthcare stocks experienced significant movements. Apollomics, SeaStar Medical Holding, Envoy Medical, Avenue Therapeutics, Zynex, and Acurx Pharmaceuticals saw gains, while Biotricity, TransCode Therapeutics, PTC Therapeutics, Sanofi, PaxMedica, and Genelux experienced losses. The movements were influenced by trading volumes and recent Q3 earnings reports.
October 27, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Acurx Pharmaceuticals shares moved upwards by 14.83% to $5.42 during Friday's session, with a trading volume of 435.7K shares.
The increase in Acurx Pharmaceuticals' stock price is likely due to increased trading volume. This could indicate a positive short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Apollomics stock rose 66.2% to $0.94 during Friday's session, with a trading volume of 85.4 million shares.
The significant rise in Apollomics' stock price is likely due to increased trading volume. This could indicate a positive short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Avenue Therapeutics stock rose 23.2% to $0.43 during Friday's session, with a trading volume of 96.2K shares.
The significant rise in Avenue Therapeutics' stock price is likely due to increased trading volume. This could indicate a positive short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Envoy Medical stock rose 25.57% to $1.42 during Friday's session.
The significant rise in Envoy Medical's stock price could indicate a positive short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
SeaStar Medical Holding stock increased by 31.94% to $1.04 during Friday's session, with a trading volume of 38.0 million shares.
The significant increase in SeaStar Medical Holding's stock price is likely due to increased trading volume. This could indicate a positive short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Zynex shares increased by 15.38% to $8.25 during Friday's session, with a trading volume of 524.7K shares. The company's Q3 earnings were released yesterday.
The increase in Zynex's stock price is likely due to the release of its Q3 earnings, which could indicate a positive short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Biotricity shares fell 24.9% to $1.45 during Friday's session, with a trading volume of 114.5K shares.
The significant fall in Biotricity's stock price is likely due to increased trading volume. This could indicate a negative short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Genelux shares decreased by 17.31% to $14.0 during Friday's session, with a trading volume of 200.0K shares.
The significant decrease in Genelux's stock price is likely due to increased trading volume. This could indicate a negative short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
PTC Therapeutics stock decreased by 22.55% to $18.55 during Friday's session, with a trading volume of 3.0 million shares. The company's Q3 earnings were released yesterday.
The decrease in PTC Therapeutics' stock price is likely due to the release of its Q3 earnings, which could indicate a negative short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
PaxMedica shares fell 19.73% to $0.18 during Friday's session, with a trading volume of 2.9 million shares.
The significant fall in PaxMedica's stock price is likely due to increased trading volume. This could indicate a negative short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
TransCode Therapeutics stock declined by 23.56% to $0.32 during Friday's session, with a trading volume of 8.3 million shares.
The significant decline in TransCode Therapeutics' stock price is likely due to increased trading volume. This could indicate a negative short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Sanofi stock declined by 19.74% to $42.8 during Friday's session, with a trading volume of 12.4 million shares. The company's Q3 earnings were released today.
The decrease in Sanofi's stock price is likely due to the release of its Q3 earnings, which could indicate a negative short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100